Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

According to MarketsandMarkets™, the Predictive Clinical Biomarkers Market is projected to grow from about USD 8.49 billion ...